Total investments received (USD): 93.71m
Round value (USD): 4.93m
Round investors:
Advent France Biotechnology
Invivo Capital
Company: Arthex Biotech S.L.
Industry:
Biotech
Health services


Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal
United Kingdom